Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs imipenem-cilastatin for ventilator-associated pneumonia
2007-004646-33Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of doripenem in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Janssen Pharmaceutical. Started Jan 2008; status: terminated.
02
Drugs
doripenem
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2007-004646-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004646-33.